- Marinus Pharmaceuticals (NASDAQ:MRNS) -66% on disappointing ganaxolone data.
- More news on: Marinus Pharmaceuticals, Inc., LSC Communications, Inc., ACADIA Pharmaceuticals Inc., Stocks on the move, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
LSC Communications, Inc. (OTCQX: LKSD) (“LSC” or the “Company”) today announced that the U.S. Bankruptcy Court for the Southern District of New York (the “Court”) has approved its previously announced stock and asset purchase agreement, under wh...
Company Expects to Exit Chapter 11 with Improved Balance Sheet and Sustainable Cost Structure Continuing to Serve Customers with the Same High Standards of Quality, Reliability and Innovation LSC Communications, Inc. (OTCQX: LKSD) (“LSC” or the “Company”...
Voluntarily Files for Business Reorganization under Chapter 11 Raises $100 Million in Additional Liquidity to Continue Operating Its Business and Serving Clients LSC Communications, Inc. (OTCQX: LKSD) (“LSC” or the “Company”) today announced that the Co...